Liquid biomarkers associate with TGF-β Type I receptor and hypoxia in kidney cancer.

IF 52.7 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Signal Transduction and Targeted Therapy Pub Date : 2025-09-26 DOI:10.1038/s41392-025-02404-7

Pramod Mallikarjuna,Cemal Erdem,Ruben Ilundain Beorlegui,Anders Larsson,Börje Ljungberg,Masood Kamali-Moghaddam,Maréne Landström

引用次数: 0

查看原文本刊更多论文

肾癌中与TGF-β I型受体和缺氧相关的液体生物标志物

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Signal Transduction and Targeted Therapy Biochemistry, Genetics and Molecular Biology-Genetics

CiteScore

44.50

自引率

1.50%

发文量

384

审稿时长

5 weeks

期刊介绍： Signal Transduction and Targeted Therapy is an open access journal that focuses on timely publication of cutting-edge discoveries and advancements in basic science and clinical research related to signal transduction and targeted therapy. Scope: The journal covers research on major human diseases, including, but not limited to: Cancer,Cardiovascular diseases,Autoimmune diseases,Nervous system diseases.